{"id":36330,"date":"2019-07-17T07:28:24","date_gmt":"2019-07-17T07:28:24","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=36330"},"modified":"2019-07-17T10:36:58","modified_gmt":"2019-07-17T10:36:58","slug":"risk-to-partners-of-people-taking-a-treatment-interruption","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/36330","title":{"rendered":"HIV risk to partners of people in studies with a treatment interruption"},"content":{"rendered":"<p class=\"HTBsubhead3authorcredit\"><strong><span lang=\"EN-US\">Simon Collins, HIV i-Base<\/span><\/strong><\/p>\n<p class=\"HTBBODYtext\"><strong><span lang=\"EN-US\">Risks to partners of HIV positive people who are enrolled in studies that include taking a treatment interruption treatment interruption are the focus of eight articles published as a supplement to the Journal of Infectious Diseases (JID).<\/span><\/strong><\/p>\n<p>The free or open access articles in this issue are:<\/p>\n<ul>\n<li class=\"HTBBODYindent\"><span lang=\"EN-US\">Risk to nonparticipants in HIV remission studies with treatment interruption: a\u00a0<\/span>symposium &#8211;\u00a0Nir Eyal and\u00a0Steven G Deeks<\/li>\n<li class=\"HTBBODYindent\">How to address the risk of HIV transmission in remission studies with treatment interruption: the low-hanging fruit approach\u00a0&#8211;\u00a0Nir Eyal<\/li>\n<li class=\"HTBBODYindent\">Human Immunodeficiency Virus transmission risk in analytical treatment interruption studies: relational factors and moral responsibility &#8211;\u00a0Liza Dawson<\/li>\n<li>Removing One barrier to protecting sex partners in HIV remission studies with a treatment interruption\u00a0&#8211;\u00a0Nir Eyal<\/li>\n<\/ul>\n<h3><b>comment<\/b><\/h3>\n<p><b>The ethics of this concern for partners is increasingly recognised by research groups with community demands also calling for access to PrEP to be included within such studies.<\/b><\/p>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">Reference<\/span><\/p>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">JID paper. Risk to Sexual Partners in HIV Remission Studies with Treatment Interruption. Selected articles. Volume 220, Issue Supplement_1, 1 August 2019.<br \/>\n<a href=\"https:\/\/academic.oup.com\/jid\/issue\/220\/Supplement_1\" rel=\"noopener\">https:\/\/academic.oup.com\/jid\/issue\/220\/Supplement_1<\/a><br \/>\n<\/span><\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>Simon Collins, HIV i-Base Risks to partners of HIV positive people who are enrolled in studies that include taking a treatment interruption treatment interruption are the focus of eight articles published as a supplement to the Journal of Infectious Diseases &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-36330","post","type-post","status-publish","format-standard","hentry","category-cure-research"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/36330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=36330"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/36330\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=36330"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=36330"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=36330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}